861 related articles for article (PubMed ID: 8380735)
1. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.
Comoglio PM
EXS; 1993; 65():131-65. PubMed ID: 8380735
[TBL] [Abstract][Full Text] [Related]
2. Identification of functional domains in the hepatocyte growth factor and its receptor by molecular engineering.
Bardelli A; Ponzetto C; Comoglio PM
J Biotechnol; 1994 Sep; 37(2):109-22. PubMed ID: 7765452
[TBL] [Abstract][Full Text] [Related]
3. The hepatocyte growth factor and its receptor.
Galimi F; Brizzi MF; Comoglio PM
Stem Cells; 1993 Jul; 11 Suppl 2():22-30. PubMed ID: 8401259
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor and its receptor, the tyrosine kinase encoded by the c-MET proto-oncogene.
Vigna E; Naldini L; Tamagnone L; Longati P; Bardelli A; Maina F; Ponzetto C; Comoglio PM
Cell Mol Biol (Noisy-le-grand); 1994 Jul; 40(5):597-604. PubMed ID: 7981617
[TBL] [Abstract][Full Text] [Related]
5. Tyrosines1234-1235 are critical for activation of the tyrosine kinase encoded by the MET proto-oncogene (HGF receptor).
Longati P; Bardelli A; Ponzetto C; Naldini L; Comoglio PM
Oncogene; 1994 Jan; 9(1):49-57. PubMed ID: 8302603
[TBL] [Abstract][Full Text] [Related]
6. Molecular characteristics of HGF-SF and its role in cell motility and invasion.
Weidner KM; Hartmann G; Naldini L; Comoglio PM; Sachs M; Fonatsch C; Rieder H; Birchmeier W
EXS; 1993; 65():311-28. PubMed ID: 8380739
[TBL] [Abstract][Full Text] [Related]
7. The cell dissociation and motility triggered by scatter factor/hepatocyte growth factor are mediated through the cytoplasmic domain of the c-Met receptor.
Komada M; Kitamura N
Oncogene; 1993 Sep; 8(9):2381-90. PubMed ID: 7689722
[TBL] [Abstract][Full Text] [Related]
8. Autophosphorylation promotes complex formation of recombinant hepatocyte growth factor receptor with cytoplasmic effectors containing SH2 domains.
Bardelli A; Maina F; Gout I; Fry MJ; Waterfield MD; Comoglio PM; Ponzetto C
Oncogene; 1992 Oct; 7(10):1973-8. PubMed ID: 1328986
[TBL] [Abstract][Full Text] [Related]
9. Isoforms of the met receptor tyrosine kinase.
Rodrigues GA; Park M
EXS; 1993; 65():167-79. PubMed ID: 8380736
[TBL] [Abstract][Full Text] [Related]
10. Signal transduction in c-met mediated motogenesis.
Faletto DL; Kaplan DR; Halverson DO; Rosen EM; Vande Woude GF
EXS; 1993; 65():107-30. PubMed ID: 8380734
[TBL] [Abstract][Full Text] [Related]
11. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
12. Isoforms of human HGF and their biological activities.
Chan A; Rubin J; Bottaro D; Hirschfield D; Chedid M; Aaronson SA
EXS; 1993; 65():67-79. PubMed ID: 8380745
[TBL] [Abstract][Full Text] [Related]
13. Receptor chimeras indicate that the met tyrosine kinase mediates the motility and morphogenic responses of hepatocyte growth/scatter factor.
Zhu H; Naujokas MA; Park M
Cell Growth Differ; 1994 Apr; 5(4):359-66. PubMed ID: 8043510
[TBL] [Abstract][Full Text] [Related]
14. Induction of met proto-oncogene (hepatocyte growth factor receptor) expression during human monocyte-macrophage differentiation.
Chen Q; DeFrances MC; Zarnegar R
Cell Growth Differ; 1996 Jun; 7(6):821-32. PubMed ID: 8780895
[TBL] [Abstract][Full Text] [Related]
15. Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells.
Halaban R; Rubin JS; Funasaka Y; Cobb M; Boulton T; Faletto D; Rosen E; Chan A; Yoko K; White W
Oncogene; 1992 Nov; 7(11):2195-206. PubMed ID: 1331934
[TBL] [Abstract][Full Text] [Related]
16. Differential signaling by alternative HGF isoforms through c-Met: activation of both MAP kinase and PI 3-kinase pathways is insufficient for mitogenesis.
Day RM; Cioce V; Breckenridge D; Castagnino P; Bottaro DP
Oncogene; 1999 Jun; 18(22):3399-406. PubMed ID: 10362361
[TBL] [Abstract][Full Text] [Related]
17. Evidence for non-covalent clusters of the c-met proto-oncogene product.
Faletto DL; Tsarfaty I; Kmiecik TE; Gonzatti M; Suzuki T; Vande Woude GF
Oncogene; 1992 Jun; 7(6):1149-57. PubMed ID: 1317541
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine phosphorylation of p145met mediated by EGFR and Src is required for serum-independent survival of human bladder carcinoma cells.
Yamamoto N; Mammadova G; Song RX; Fukami Y; Sato K
J Cell Sci; 2006 Nov; 119(Pt 22):4623-33. PubMed ID: 17062641
[TBL] [Abstract][Full Text] [Related]
19. Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma.
Rahimi N; Tremblay E; McAdam L; Park M; Schwall R; Elliott B
Cell Growth Differ; 1996 Feb; 7(2):263-70. PubMed ID: 8822210
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of junction assembly in cultured epithelial cells by hepatocyte growth factor/scatter factor is concomitant with increased stability and altered phosphorylation of the soluble junctional molecules.
Pasdar M; Li Z; Marreli M; Nguyen BT; Park M; Wong K
Cell Growth Differ; 1997 Apr; 8(4):451-62. PubMed ID: 9101091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]